AACE Master Class series 2020
Topics:
Diabetes
– AACE_ACE Comprehensive Type 2 Diabetes Management Algorithm
– Diabetic Ketoacidosis in Non-Type 1 Diabetes
– How Does One Set Up Diabetes Technology and Survive in the Private Practice Setting-
– Managing Type 2 Diabetes in Younger Populations – Epidemiology and Trends of Type 2 Diabetes Among Youths
– Novel Therapies for Diabetic Kidney Disease
– Personalizing Therapies for the Prevention of Type 1 Diabetes- Searching for Endotypes
Thyroid
– Advanced Thyroid Cancer Frontiers II- TKI Treatment When Do We Start?
– Anaplastic Thyroid Cancer in 2020 – The Emerging Role of Neoadjuvant Therapy and Surgery for BRAF-Mutated Disease
– DSN Year in Review- Thyroid DSN
– Graves Disease in Pregnancy
– Preop Cancer Frontiers I- FNA Mutational Data and Extent of Surgery Decisions
– Preop Cancer Frontiers II- Medullary Thyroid Cancer – Can We Miss It?
– Thyroid and Diet
– Thyroid Autoimmunity in Pregnancy and the Postpartum
– Ultrasound Evaluation and Analysis of Thyroid Nodules
– Ultrasound Evaluation of Diffuse Thyroid Disease and Thyroiditis
– Ultrasound Guided Fine Needle Aspiration
Bone
– 2020 AACE Postmenopausal Osteoporosis Treatment Guidelines
– Atypical Femur Fractures- Site, Type, and Management Considerations
– Bone Fragility in Type I and Type II Diabetes
– Bone Health in Transgender Patients
– Clinical Pearls in Hypercalcemia
– DSN Year in Review – Bone
– FRAX Flaws and Atlernative Fracture Risk Assessment Tools
– Identification and Management Strategies for Vertebral Fractures as part of a larger symposium on Fractures – Site, Type, and Management Considerations
– Long Term Osteoporosis Therapies- Drug Interruption and Monitoring
– Metabolic & Bariatric Surgery- Good for Diabetes, but Bad for the Bones
– Normocalcemic and Normohorhormonal Primary Hyperparathyroidism
– Postsurgical Hypoparathyroidism- Morbidity and Medical Management
– Primary Hyperparathyroidism 2020- The Parathyroid Glands & Cardiovascular Disease
– Revision Parathyroidectomy – Current Guidelines Statements
– Secondary Hyperparathyroidism
– Surgical Treatment – Latest on Parathyroid Auto Fluorescence and ICG Angiography
Lipids and Cardiovascular Health
– Clinical Lipidology for the Endocrinologist
– Clinical Lipidology for the Endocrinologist – Individualizing Lipid Lowering Therapy
– Coronary Artery Calcium Scanning
– Lipids and Cardiovascular Health DSN 2020 Year in Review
– Lipoprotein(a), Cardiovascular Disease, and Calcific Aortic Valve Stenosis
– Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes- Time for Endocrinologists to Take Action
– Rare Lipid Disorders for the Endocrinologist
– AACE_ACE- 2020 Algorithm for the Management of Dyslipidemia and Prevention of Cardiovascular Disease
Nutrition and Obesity
– Can Technology Improve Measurement of Nutrition and Physical Activity-
– DSN Year in Review- Obesity and Nutrition
– Eat Fat to Lose Weight- the Low Carbohydrate, High Fat Diet
– Non-nutritive Sweeteners and Obesity
– Nutrition and Cardiovascular Mortality
– Primary Endoscopic Weight Loss and Metabolic Therapies – Current and Future Technologies
Pituitary, Gonad, Adrenal and Neuroendocrine
– Adult GHD – New Guidelines and How to Incorporate into Clinical Practice
– Bias in Clinical Reasoning- A Case-Based Discussion with Practical Takeaways
– DSN Year in Review- PGAN
– Evaluation and Management of Adrenal Masses
– Gender-Specific Characteristics in Acromegaly
– Laboratory Testing in Endocrinology- The Highs and the Lows
– Management of Prolactin – and GH – Secreting Adenomas During Pregnancy
– Medical Therapies for Acromegaly in the Era of Precision Medicine
– Non-tumoral Hyperprolactinemia
– Pheochromocytoma and Pseudopheochromocytoma
– Pituitary Stalk Thickening- Differential dx and Management
– Rationale for and Practical Progesterone Therapy for Transwomen
– Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement-
– Sodium Perturbations after Pituitary Surgery
– What’s New in the Treatment of Neuroendocrine Tumors-
Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Time for Endocrinologists to Take Action
– Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Time for Endocrinologists to Take Action
Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement
– Should Older Men with Age-Related Decline in Testosterone levels Receive Testosterone Replacement
Personalizing Therapies for the Prevention of Type 1 Diabetes Searching for Endotypes
– Personalizing Therapies for the Prevention of Type 1 Diabetes Searching for Endotypes
Clinical Science Late-breaking Presentations
– Diagnostic-Accuracy-of-DHEAS-in-Mild-Autonomous-Cortisol-Secretion
– Glycemic-Control-In-Patients-Achieving-Diabetes-Remission-With-Weight-Loss-By-Bariatric-Surgery
Oral Poster Presentations
– Acceptability and Feasibility of an Innovative, User-Friendly, Interactive Technology-Based Lifestyle Intervention for Weight Loss
– Arterial Stiffness and Hepatic Fibrosis in Nash Have Independently Significant, Bilateral Correlation in Adults with Type 2 Diabetes
– Genetic Predictors of Differences in Continuous Glycemic Curve Parameters in Patients with Type 2 Diabetes Receiving Vildagliptin Therapy
– Impact of Thyroid Hormone Replacement on the Incidence of Heart Failure
– Levoketoconazole in the Treatment of Endogenous Cushing’s Syndrome- Extended Evaluation Phase Results of the Sonics Study
– Risk Stratification for Patients with Papillary Thyroid Microcarcinoma – A Retrospective Cohort Study
– Treatment with Oral Octreotide Capsules May Not Influence Glycemic Control in Patients with Acromegaly- Results from the Phase 3 Chiasma Optimal Study
